Preferred Label : Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone Regimen;
NCIt synonyms : Daratumumab and Hyaluronidase-Vd Regimen; Bortezomib-Daratumumab and Hyaluronidase-Dexamethasone Regimen; Velcade-Decadron Plus Darzalex Faspro Regimen; Bortezomib-Dexamethasone Plus Daratumumab and Hyaluronidase-fihj; Daratumumab/Recombinant Human Hyaluronidase/Bortezomib/Dexamethasone Regimen; Daratumumab and Hyaluronidase-fihj/Bortezomib/Dexamethasone Regimen; DVD (Daratumumab SC); Bortezomib-Dexamethasone Plus Daratumumab and Hyaluronidase; Daratumumab/Hyaluronidase Bortezomib-Dexamethasone; Bortezomib/Dexamethasone Plus Darzalex Faspro; Darzalex Faspro/Bortezomib/Dexamethasone Regimen; Daratumumab and Hyaluronidase/Bortezomib/Dexamethasone Regimen; Bortezomib/Daratumumab and Hyaluronidase/Dexamethasone; Daratumumab-Hyaluronidase/Bortezomib/Dexamethasone; Bortezomib-Darzalex Faspro-Dexamethasone; Daratumumab/Hyaluronidase-Vd Regimen; Daratumumab Subcutaneous-Bortezomib-Dexamethasone Regimen; Darzalex Faspro/Velcade/Decadron Regimen; Bortezomib/Dexamethasone Plus Daratumumab and Hyaluronidase Regimen; Dara (Daratumumab Subcutaneous)-VD Regimen; Daratumumab SC-Vd Regimen; Bortezomib/Daratumumab and Hyaluronidase-fihj/Dexamethasone Regimen;
NCIt related terms : Dara-Vd (SC daratumumab);
NCIt definition : A regimen consisting of bortezomib, daratumumab and hyaluronidase, and dexamethasone
that is used for the treatment of plasma cell myeloma.;
Codes from synonyms : 16946;
Origin ID : C201868;
chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
